CCL11 and early-onset autosomal dominant Alzheimer disease: Increased CCL-11 production in the course of immune-mediated inflammatory conditions may play a role in age-related cognitive decline, schizophrenia, mood disorders, Alzheimer’s disease, OCD and ASD.